Exploring symptoms and balance in rectal cancer patients
Changes of Low Anterior Resection Syndrome, Balance Ability, and Quality of Life in Patients with Newly Diagnosed Rectal Cancer.
This study looks at how symptoms and balance change over time in people who have just been diagnosed with rectal cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 110 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Taoyuan City, Kwei-Shan Dist.) |
| Trial ID | NCT06006260 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the changes in symptom distress and balance ability among patients newly diagnosed with rectal cancer. It will involve assessing patients' experiences and physical capabilities over time to understand the impact of their condition. Participants will be required to communicate in Mandarin or Taiwanese and provide consent for interviews. The study focuses on gathering qualitative and quantitative data to inform future patient care.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 20 years and older who have been newly diagnosed with rectal cancer and can communicate in Mandarin or Taiwanese.
Not a fit: Patients with recurrent rectal cancer or a Karnofsky Performance Status (KPS) of less than 80 may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the challenges faced by rectal cancer patients, leading to improved management strategies.
How similar studies have performed: While there may be studies focusing on symptom management in cancer patients, this specific approach to balance ability in rectal cancer is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Newly diagnosed rectal cancer 2. Patients already know their condition. 3. Aged 20 years and older. 4. Consciously communicate in Mandarin or Taiwanese. 5. Agreed with the interview and had signed the permit. Exclusion Criteria: 1. Recurrent rectal cancer. 2. KPS of patients less than 80
Where this trial is running
Taoyuan City, Kwei-Shan Dist.
- Chung Gung University — Taoyuan City, Kwei-Shan Dist., Taiwan (Recruiting)
Study contacts
- Study coordinator: Yun-Jen Chou, PhD
- Email: yjchou@mail.cgu.edu.tw
- Phone: +886-3-2118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.